Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arm Holdings plc (ARM) vs Novo Nordisk A/S (NVO) Price & Performance

Arm Holdings plcTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

Arm Holdings plc vs Novo Nordisk A/S — how do they compare? Arm Holdings plc trades at $273.33 (market cap $287.22B), while Novo Nordisk A/S trades at $45.89 (market cap $207.85B). The key difference: Arm Holdings plc is the larger of the two by market cap, and Novo Nordisk A/S pays a 3.81% dividend while Arm Holdings plc pays none. Which is the better fit depends on your goals.

ARMNVO
Market Cap
$287.22B$207.85B
Sector
TechnologyHealth
52-Week High
$439.46$63.98
52-Week Low
$104.55$35.29
Enterprise Value
$283.79B$222.55B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arm Holdings plc

Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.

Read more on ARM

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO